abstract |
The present invention provides methods and compositions for inhibiting atherosclerosis formation in a subject. In certain embodiments, the methods of the invention comprise the step of selecting a subject having or at risk of developing atherosclerosis and a pharmaceutical composition comprising a pro-protein converting enzyme subtilisin / Texx 9 (PCSK9) inhibitor, Lt; / RTI > In certain embodiments, the PCSK9 inhibitor is an anti-PCSK9 antibody or antigen binding protein. |